Staff Research Interests

Staff Member Research Interests

Dr Evin Allen


  • Biopharmaceutical Drug product manufacture
  • Single Use Technology
  • Container Closure Integrity 
  • Freeze Drying
  • Filling processes
  • Education of the (bio)pharmaceutical sector
  • Knowledge Management 

Dr Teresa Barbosa

Clinical Pharmacy

  • Infectious disease
  • Antimicrobials, antimicrobial resistance and stewardship
  • Long term impact of antimicrobial
  • Education and training on antimicrobials and

Dr Lorraine Bateman

Pharmaceutical Chemistry 

  • Nuclear Magnetic Resonance (NMR) Spectroscopy as a key technique for Pharmaceutical synthesis and analysis
  • Pharmaceutical Chemistry Process; in situ reaction monitoring
  • Advanced structure and mechanism elucidation
  • Dynamic systems, systems in equilibrium

Dr Harriet Bennett-Lenane

Clinical Pharmaceutics

  • Machine Learning-Informed Medicines Optimisation.
  • Computational Pharmaceutics-informed Drug Delivery.
  • Digitalisation of  Pharmacy Practice.  
  • Delivery of Community Pharmacy Services to Vulnerable Patient Groups.
  • Career Pathways and Motivators of Pharmacy Students and Graduates.

Dr Margaret Bermingham

Clinical Pharmacy

  • Prevention and treatment of chronic disease with a focus on cardiovascular disease and diabetes
  • Chronic disease and medicines management in primary and secondary care
  • Biosimilar medicines

Prof Stephen Byrne

Clinical Pharmacy

  • The use of screening tools to aid in the identification of inappropriately prescribed medicines in a primary and secondary care setting
  • Enhancing the role of the community and hospital pharmacists in monitoring and optimising prescribing
  • The Use of the Behavioural Change Wheel to enhance pharmacists interventions
  • Pharmacoeconomics and Pharmacoepidemiology

Prof Abina Crean


  • Development of formulation approaches to enhance the oral bioavailability of drug molecules challenged by poor-water solubility
  • Formulation and characterisation of microneedle drug delivery systems
  • Investigating critical attributes of drugs and excipients that impact on the processing and performance of drug products
  • Biophysical characterisation, processing and formulation of peptide, protein and vaccine therapeutics and medical devices

Dr Kieran Dalton

Clinical Pharmacy

  • Pharmacist prescribing in hospital settings
  • Prescribing optimisation in older adults
  • Role of pharmacists in general practice settings
  • Communication between healthcare professionals
  • Pharmacy education research and interprofessional learning

Dr Maria Donovan

Clinical Pharmacy

  • Pharmacokinetic modelling 
  • Technology-enhanced learning in healthcare 
  • Experiential learning
  • Deprescribing in community pharmacy

Dr Aoife Fleming

Clinical Pharmacy

  • Antimicrobial Stewardship
  • Infection biomarkers (C reactive protein, procalcitonin)
  • Vaccinations: role of the healthcare professional & hesitancy
  • Prescribing and medication management in long term care facilities
  • Medication safety and reconciliation
  • Behaviour Change interventions

Dr Eoin Fleming


  • Diseases of protein misfolding
  • Inflammation
  • Cancer

Prof Cormac Gahan


  • Functional Metagenomics of the GI tract
  • Host-Pathogen interactions in the GI tract
  • Development of Novel Vaccines
  • Bactofection & DNA Delivery

Prof Brendan Griffin


  • Targeted drug delivery
  • Oral drug delivery systems
  • Nano drug delivery

Dr J J Keating

Pharmaceutical Chemistry 

  • Impurity profiling on amphetamine-type drugs of abuse
  • Independent synthesis of impurities arising from synthetic routes to amphetamine analogues
  • Synthetic and biological activity of compounds which increase brain serotonin levels

Dr Piotr Kowalski


  • nanotechnology
  • nucleic acid delivery
  • biomaterials engineering
  • gene therapy
  • cancer and inflammatory diseases

Prof Anita Maguire

Pharmaceutical Chemistry 

  • Novel synthetic methodology including the use of α diazocarbonyl compounds and organosulfur compounds in synthesis
  • Asymmetric synthesis including asymmetric catalysis and application of biotransformations in organic synthesis
  • Continuous flow as a powerful technique to enhance process chemistry
  • Synthesis of biologically active compounds Current projects are targeted towards compounds with anti-viral activity
  • Crystal engineering – the pharmaceutical solid state

Dr Suzanne McCarthy

Clinical Pharmacy

  • Healthcare Education Research
  • Medication Safety
  • Women’s and Children’s health
  • Mental Health
  • Pharmacoepidemiology/Drug Utilisation

Dr Rachel Moloney


  • Stress neurobiology: Understanding the role of the Hypothalamic Pituitary Adrenal Axis (HPA) and the impact of traumatic stress in fear memory, anxiety and depression
  • Limbic neurocircuitry: Investigating the roles of discrete brain regions using cutting edge tools such as DREADDs/chemogenetics to directly manipulate neurocircuitry
  • Brain-gut-microbiome axis: Studying the role of the gut microbiome in stress-related illnesses
  • Pain: Investigating the impact of stress on pain sensitivity and nociception

Dr Kevin Murphy

Clinical Pharmacy

  • Reducing deleterious effects of polypharmacy in older patients
  • Interprofessional communication and patient communication
  • Expanding pharmacy services in hospital environment

Prof Caitriona O'Driscoll


  • Physicochemical and physiological barriers to drug delivery
  • Design and assessment of targeted drug delivery constructs
  • Delivery of macromolecules including peptide/protein based drugs
  • Non-viral methods for delivery of plasmid DNA and siRNA
  • Oral drug absorption using lipid-based formulations
  • Bioavailability and pharmacokinetics

Dr Patrick O'Dwyer


  • Biopharmaceutical profiling including biorelevant dissolution testing & Physiologically based pharmacokinetic (PBPK) modelling / Physiologically Based Biopharmaceutics Modelling (PBBM)
  • Computational Pharmaceutics: applying machine learning and artificial intelligence to address pharmaceutical challenges, including formulation & process development
  • Regulatory Science eg., applying innovative approaches to develop and assess complex generic products, such as inhalers
  • Novel approaches to enhance oral drug delivery

Dr Joey O'Shea


  • Formulation development and characterisation for oral drug delivery of poorly soluble drugs.
  • Lipid-based formulations for oral drug
  • Computational biopharmaceutics and predictive modelling of bioavailability and pharmacokinetics.
  • Development of nanoparticulate preparations for delivery of advanced

Dr Tim O'Sullivan

Pharmaceutical Chemistry 

  • Synthesis of bioactive compounds, including antiparasitic, antibacterial and antiviral compounds.
  • Development of new methodologies for the synthesis of medicinally important compounds.
  • Stereoselective synthesis of natural 1,2-dioxanes for the treatment of Chagas disease.
  • Investigation of new chiral tethers for the control of intramolecular, aryl-aryl coupling and application to anti-HIV biaryls.
  • Synthesis of Diffusible Signal Factor analogues to disrupt bacterial resistance in Cystic Fibrosis lung.

Dr Katie Ryan


  • Formulation approaches for poorly soluble drugs.
  • Nanotechnology for targeted drug delivery.
  • Biomaterials.
  • Medical devices including hard and soft tissue implants.
  • Regenerative medicine and tissue engineering.

Prof Laura Sahm

Clinical Pharmacy

  • The role of the pharmacist in Public Health including; vaccinations and modification of solid oral dosage forms.
  • Patient adherence to therapy and Health Literacy.
  • Pharmacovigilance and the importance of medication reconciliation at the interface of primary and secondary care.

Dr Sonja Vucen


  • Transdermal drug delivery and enhancement of percutaneous absorption.
  • Prediction and assessment of skin penetration and topical bioavailability and pharmacokinetics.
  • Skin barrier function characterization.
  • Design and assessment of microneedle drug delivery systems.
  • Formulation and characterisation of peptide and protein therapeutics.

Prof Christian Waeber


  • Vascular biology: Investigating the role of S1P receptors, S1P synthesizing. enzyme and Store-Operated Calcium Entry in vascular disorders associated smooth muscle cell proliferation.
  • Stroke and Neuroprotection: Studying the mechanisms by which S1P receptor stimulation in effective in rodent models of cerebral ischemia. Assessing the translational significance of these protective effects by using stroke models that are more relevant to humans (thromboembolic stroke, effect of comorbidities, age, etc.).
  • Bone biology: Polymer-based delivery of S1P agents for bone repair.

School of Pharmacy


Pharmacy Building Room UG06 University College Cork